8
Registered trials
5
Recruiting
8
Unique sponsors
7
Unique IMPs
1
Commercial trials
Drug classes (ATC)
—
ATC code not specified
2
J
Anti-infectives (ATC J)
1
N
Neurology/Psychiatry (ATC N)
1
H
Endocrinology (ATC H)
3
V
Various (ATC V)
1
B
Haematology (ATC B)
1
Mechanism of action (INN-stem analysis)
Unknown / small molecule
6 substances
Supportive / diluent
1 substance
Phase III:
3
Phase II:
2
Phase IV:
2
Phase I (Other):
1
Phase III
3 trials-
RecruitingAssistance Publique Hopitaux De Paris AcademicLEVETIRACETAM
-
RecruitingCentre Hospitalier Regional De Marseille AcademicARGIPRESSIN
-
EndedFundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla AcademicTERLIPRESSIN ACETATE
Phase II
2 trials-
RecruitingFakultni Nemocnice Plzen AcademicIMP not specified
-
RecruitingUniversitaetsklinikum Aachen AöR AcademicIMMUNOGLOBULIN A, IMMUNOGLOBULIN G, IMMUNOGLOBULIN M
Phase IV
2 trials-
RecruitingAzienda Unita Sanitaria Locale Di Bologna AcademicARGIPRESSIN; SULFUR HEXAFLUORIDE
-
EndedPontificia Universidad Catolica de Chile AcademicPOTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE DIHYDRATE, SODIUM LACTATE; SODIUM CHLORIDE
Phase I (Other)
1 trial-
EndedMatisse Pharmaceuticals B.V. CommercialIMP not specified
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Matisse Pharmaceuticals B.V. | Commercial | 1 | Phase I (Other) | 0 |
| Fakultni Nemocnice Plzen | Academic | 1 | Phase II | 1 |
| Universitaetsklinikum Aachen AöR | Academic | 1 | Phase II | 1 |
| Assistance Publique Hopitaux De Paris | Academic | 1 | Phase III | 1 |
| Centre Hospitalier Regional De Marseille | Academic | 1 | Phase III | 1 |
| Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla | Academic | 1 | Phase III | 0 |
| Azienda Unita Sanitaria Locale Di Bologna | Academic | 1 | Phase IV | 1 |
| Pontificia Universidad Catolica de Chile | Academic | 1 | Phase IV | 0 |
New trials by year
2022
1
2024
3
2025
2
2026
1